This report aims to provide a comprehensive presentation of the global market for Oral Antituberculosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antituberculosis Drugs. This report contains market size and forecasts of Oral Antituberculosis Drugs in global, including the following market information:
Global Oral Antituberculosis Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Oral Antituberculosis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Isoniazid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Antituberculosis Drugs include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Oral Antituberculosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Antituberculosis Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, by Type, 2022 (%)
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Global Oral Antituberculosis Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Global Oral Antituberculosis Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Oral Antituberculosis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Antituberculosis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oral Antituberculosis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Antituberculosis Drugs, market overview.
Chapter 2: Global Oral Antituberculosis Drugs market size in revenue.
Chapter 3: Detailed analysis of Oral Antituberculosis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Antituberculosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Antituberculosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Antituberculosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Antituberculosis Drugs Overall Market Size
2.1 Global Oral Antituberculosis Drugs Market Size: 2022 VS 2030
2.2 Global Oral Antituberculosis Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Antituberculosis Drugs Players in Global Market
3.2 Top Global Oral Antituberculosis Drugs Companies Ranked by Revenue
3.3 Global Oral Antituberculosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oral Antituberculosis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oral Antituberculosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Antituberculosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oral Antituberculosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Antituberculosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Antituberculosis Drugs Market Size Markets, 2022 & 2030
4.1.2 Isoniazid
4.1.3 Rifampin
4.1.4 Ethambutol
4.1.5 Pyrazinamide
4.1.6 Otherr
4.2 By Type - Global Oral Antituberculosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Oral Antituberculosis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oral Antituberculosis Drugs Revenue, 2024-2030
4.2.3 By Type - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Antituberculosis Drugs Market Size, 2022 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Government Agencies
5.1.4 Non-Profit Organizations
5.1.5 Others
5.2 By Application - Global Oral Antituberculosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Oral Antituberculosis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oral Antituberculosis Drugs Revenue, 2024-2030
5.2.3 By Application - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Oral Antituberculosis Drugs Market Size, 2022 & 2030
6.2 By Region - Global Oral Antituberculosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Antituberculosis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oral Antituberculosis Drugs Revenue, 2024-2030
6.2.3 By Region - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Oral Antituberculosis Drugs Revenue, 2018-2030
6.3.2 US Oral Antituberculosis Drugs Market Size, 2018-2030
6.3.3 Canada Oral Antituberculosis Drugs Market Size, 2018-2030
6.3.4 Mexico Oral Antituberculosis Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Oral Antituberculosis Drugs Revenue, 2018-2030
6.4.2 Germany Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.3 France Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.4 U.K. Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.5 Italy Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.6 Russia Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Oral Antituberculosis Drugs Market Size, 2018-2030
6.4.8 Benelux Oral Antituberculosis Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Oral Antituberculosis Drugs Revenue, 2018-2030
6.5.2 China Oral Antituberculosis Drugs Market Size, 2018-2030
6.5.3 Japan Oral Antituberculosis Drugs Market Size, 2018-2030
6.5.4 South Korea Oral Antituberculosis Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Oral Antituberculosis Drugs Market Size, 2018-2030
6.5.6 India Oral Antituberculosis Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Oral Antituberculosis Drugs Revenue, 2018-2030
6.6.2 Brazil Oral Antituberculosis Drugs Market Size, 2018-2030
6.6.3 Argentina Oral Antituberculosis Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Antituberculosis Drugs Revenue, 2018-2030
6.7.2 Turkey Oral Antituberculosis Drugs Market Size, 2018-2030
6.7.3 Israel Oral Antituberculosis Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Oral Antituberculosis Drugs Market Size, 2018-2030
6.7.5 UAE Oral Antituberculosis Drugs Market Size, 2018-2030
7 Oral Antituberculosis Drugs Companies Profiles
7.1 Lupin
7.1.1 Lupin Company Summary
7.1.2 Lupin Business Overview
7.1.3 Lupin Oral Antituberculosis Drugs Major Product Offerings
7.1.4 Lupin Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.1.5 Lupin Key News & Latest Developments
7.2 Macleods Pharmaceuticals
7.2.1 Macleods Pharmaceuticals Company Summary
7.2.2 Macleods Pharmaceuticals Business Overview
7.2.3 Macleods Pharmaceuticals Oral Antituberculosis Drugs Major Product Offerings
7.2.4 Macleods Pharmaceuticals Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.2.5 Macleods Pharmaceuticals Key News & Latest Developments
7.3 Otsuka Pharmaceutical
7.3.1 Otsuka Pharmaceutical Company Summary
7.3.2 Otsuka Pharmaceutical Business Overview
7.3.3 Otsuka Pharmaceutical Oral Antituberculosis Drugs Major Product Offerings
7.3.4 Otsuka Pharmaceutical Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.3.5 Otsuka Pharmaceutical Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Oral Antituberculosis Drugs Major Product Offerings
7.4.4 Johnson & Johnson Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Oral Antituberculosis Drugs Major Product Offerings
7.5.4 Pfizer Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Oral Antituberculosis Drugs Major Product Offerings
7.6.4 Novartis Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Oral Antituberculosis Drugs Major Product Offerings
7.7.4 Abbott Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Oral Antituberculosis Drugs Major Product Offerings
7.8.4 AstraZeneca Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Oral Antituberculosis Drugs Major Product Offerings
7.9.4 Bayer Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Oral Antituberculosis Drugs Major Product Offerings
7.10.4 Eli Lilly Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Oral Antituberculosis Drugs Major Product Offerings
7.11.4 GlaxoSmithKline Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Oral Antituberculosis Drugs Major Product Offerings
7.12.4 Merck Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Oral Antituberculosis Drugs Major Product Offerings
7.13.4 Sanofi Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 Chongqing Huapont Pharm
7.14.1 Chongqing Huapont Pharm Company Summary
7.14.2 Chongqing Huapont Pharm Business Overview
7.14.3 Chongqing Huapont Pharm Oral Antituberculosis Drugs Major Product Offerings
7.14.4 Chongqing Huapont Pharm Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.14.5 Chongqing Huapont Pharm Key News & Latest Developments
7.15 Shuangding Pharm
7.15.1 Shuangding Pharm Company Summary
7.15.2 Shuangding Pharm Business Overview
7.15.3 Shuangding Pharm Oral Antituberculosis Drugs Major Product Offerings
7.15.4 Shuangding Pharm Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.15.5 Shuangding Pharm Key News & Latest Developments
7.16 Hongqi pharmaceutical
7.16.1 Hongqi pharmaceutical Company Summary
7.16.2 Hongqi pharmaceutical Business Overview
7.16.3 Hongqi pharmaceutical Oral Antituberculosis Drugs Major Product Offerings
7.16.4 Hongqi pharmaceutical Oral Antituberculosis Drugs Revenue in Global Market (2018-2023)
7.16.5 Hongqi pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Antituberculosis Drugs Market Opportunities & Trends in Global Market
Table 2. Oral Antituberculosis Drugs Market Drivers in Global Market
Table 3. Oral Antituberculosis Drugs Market Restraints in Global Market
Table 4. Key Players of Oral Antituberculosis Drugs in Global Market
Table 5. Top Oral Antituberculosis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oral Antituberculosis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oral Antituberculosis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oral Antituberculosis Drugs Product Type
Table 9. List of Global Tier 1 Oral Antituberculosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Antituberculosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Antituberculosis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Oral Antituberculosis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oral Antituberculosis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Oral Antituberculosis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Oral Antituberculosis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oral Antituberculosis Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Oral Antituberculosis Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Oral Antituberculosis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oral Antituberculosis Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oral Antituberculosis Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oral Antituberculosis Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oral Antituberculosis Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oral Antituberculosis Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oral Antituberculosis Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Lupin Company Summary
Table 31. Lupin Oral Antituberculosis Drugs Product Offerings
Table 32. Lupin Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Lupin Key News & Latest Developments
Table 34. Macleods Pharmaceuticals Company Summary
Table 35. Macleods Pharmaceuticals Oral Antituberculosis Drugs Product Offerings
Table 36. Macleods Pharmaceuticals Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Macleods Pharmaceuticals Key News & Latest Developments
Table 38. Otsuka Pharmaceutical Company Summary
Table 39. Otsuka Pharmaceutical Oral Antituberculosis Drugs Product Offerings
Table 40. Otsuka Pharmaceutical Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Otsuka Pharmaceutical Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Oral Antituberculosis Drugs Product Offerings
Table 44. Johnson & Johnson Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Oral Antituberculosis Drugs Product Offerings
Table 48. Pfizer Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Oral Antituberculosis Drugs Product Offerings
Table 52. Novartis Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Oral Antituberculosis Drugs Product Offerings
Table 56. Abbott Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Abbott Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Oral Antituberculosis Drugs Product Offerings
Table 60. AstraZeneca Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Oral Antituberculosis Drugs Product Offerings
Table 64. Bayer Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Oral Antituberculosis Drugs Product Offerings
Table 68. Eli Lilly Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Oral Antituberculosis Drugs Product Offerings
Table 72. GlaxoSmithKline Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Oral Antituberculosis Drugs Product Offerings
Table 76. Merck Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Oral Antituberculosis Drugs Product Offerings
Table 80. Sanofi Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Chongqing Huapont Pharm Company Summary
Table 83. Chongqing Huapont Pharm Oral Antituberculosis Drugs Product Offerings
Table 84. Chongqing Huapont Pharm Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Chongqing Huapont Pharm Key News & Latest Developments
Table 86. Shuangding Pharm Company Summary
Table 87. Shuangding Pharm Oral Antituberculosis Drugs Product Offerings
Table 88. Shuangding Pharm Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Shuangding Pharm Key News & Latest Developments
Table 90. Hongqi pharmaceutical Company Summary
Table 91. Hongqi pharmaceutical Oral Antituberculosis Drugs Product Offerings
Table 92. Hongqi pharmaceutical Oral Antituberculosis Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Hongqi pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Oral Antituberculosis Drugs Segment by Type in 2022
Figure 2. Oral Antituberculosis Drugs Segment by Application in 2022
Figure 3. Global Oral Antituberculosis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Antituberculosis Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Oral Antituberculosis Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Antituberculosis Drugs Revenue in 2022
Figure 8. By Type - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Oral Antituberculosis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Oral Antituberculosis Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 16. US Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 28. China Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Oral Antituberculosis Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Oral Antituberculosis Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Lupin Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Macleods Pharmaceuticals Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Otsuka Pharmaceutical Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbott Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GlaxoSmithKline Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sanofi Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Chongqing Huapont Pharm Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Shuangding Pharm Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Hongqi pharmaceutical Oral Antituberculosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
